Journal of the Egyptian National Cancer Institute

Keyphrases

Publications

volume 35, number 1, 2023

Eman Mohamad Ibrahim, Sherine Refat, Shaimaa El-Ashwah, Maryan Waheeb Fahmi, Afaf Taha Ibrahiem
Programmed death ligand 1 expression in diffuse large B cell lymphoma: correlation with clinicopathological prognostic factors. Journal of the Egyptian National Cancer Institute 35 (1) (2023)
Mohamed Said Ismail, Loay Kassem, Ahmed Al-Husseiny Ali, Fatma Elzahraa Ahmed, Mohamed Shalaby, Sally Magdy
Molecular patterns of egyptian patients with non-squamous non-small-cell lung cancers: a clinicopathological study. Journal of the Egyptian National Cancer Institute 35 (1) (2023)
Mai Sabry Saleh, Asmaa Mahmoud Mohammed, Dina Bassiouni, Hend Helmy Mostafa, Zeinab Mohammed Monir
Evaluation of health-related quality of life and its domains in pediatric patients with cancer. Journal of the Egyptian National Cancer Institute 35 (1) (2023)
Yahia Ismail, Amr Kamal, Rasha Allam, Al-Shimaa Zakaria
The conundrum of metaplastic breast cancer: a single Egyptian institution retrospective 10-year experience (2011-2020). Journal of the Egyptian National Cancer Institute 35 (1) (2023)
Umesh Jayarajah, Ravindri Jayasinghe, Ashan Fernando, Sanjeewa Seneviratne
The incidence and trends of laryngeal malignancies in Sri Lanka from 2001 to 2019: a Joinpoint analysis of the national cancer database. Journal of the Egyptian National Cancer Institute 35 (1) (2023)
Patrick Odhiambo, Harrison Okello, Annette Wakaanya, Clabe Wekesa, Patrick Okoth
Mutational signatures for breast cancer diagnosis using artificial intelligence. Journal of the Egyptian National Cancer Institute 35 (1) (2023)
F Safini, B Amaoui, S Semghouli, N Aqodad
Organ preservation strategy: new therapeutic alternative in rectal cancer. Journal of the Egyptian National Cancer Institute 35 (1) (2023)
F Safini, B Amaoui, S Semghouli, N Aqodad
Organ preservation strategy: new therapeutic alternative in rectal cancer. Journal of the Egyptian National Cancer Institute 35 (1) (2023)
Sanaa A El-Benhawy, Ibrahim G Abdelrhman, Nadia A Sadek, Enayat I Fahmy, Ahmed A AboGabal, Hossam Elmasry, Sally A M Saleh, Ola A Sakr, Mona Nagy Elwany, Maha Abubakr Feissal Rabie
Studying ferroptosis and iron metabolism pre- and post-radiotherapy treatment in breast cancer patients. Journal of the Egyptian National Cancer Institute 35 (1) (2023)
Umesh Jayarajah, Ravindri Jayasinghe, Ashan Fernando, Sanjeewa Seneviratne
The incidence and trends of laryngeal malignancies in Sri Lanka from 2001 to 2019: a Joinpoint analysis of the national cancer database. Journal of the Egyptian National Cancer Institute 35 (1) (2023)
Rashed Pourhamidi, Azam Moslemi
Using the Precision Lasso for gene selection in diffuse large B cell lymphoma cancer. Journal of the Egyptian National Cancer Institute 35 (1) (2023)
Avinash Khadela, Bhavin Vyas, Mustakim Mansuri, Dipen Sureja, Kunjan Bodiwala
Impact of cetuximab plus cisplatin alone and cetuximab plus cisplatin and paclitaxel regimen on humanistic outcome in head and neck cancer. Journal of the Egyptian National Cancer Institute 35 (1) (2023)
Mahdiyar Iravani Saadi, Mohsen Nikandish, Zahra Ghahramani, Fatemeh Mardani Valandani, Maryam Ahmadyan, Fakhroddin Hosseini, Zahra Rahimian, Heeva Jalali, Fataneh Tavasolian, Ehsan Nabi Abdolyousefi, Nadiya Kheradmand, Mani Ramzi
miR-155 and miR-92 levels in ALL, post-transplant aGVHD, and CMV: possible new treatment options. Journal of the Egyptian National Cancer Institute 35 (1) (2023)
Patrick Odhiambo, Harrison Okello, Annette Wakaanya, Clabe Wekesa, Patrick Okoth
Mutational signatures for breast cancer diagnosis using artificial intelligence. Journal of the Egyptian National Cancer Institute 35 (1) (2023)
Iyshwarya Bhaskar Kalarani, Ganesan Sivamani, Ramakrishnan Veerabathiran
Identification of crucial genes involved in thyroid cancer development. Journal of the Egyptian National Cancer Institute 35 (1) (2023)
Ahmed Daif, Mahmood A Al-Azzawi, Moustafa A Sakr, Hisham A Ismail, Mahmoud Gadallah
Noninvasive identification of molecular biomarkers of hepatocellular carcinoma in HCV-Egyptian patients. Journal of the Egyptian National Cancer Institute 35 (1) (2023)
F Safini, B Amaoui, S Semghouli, N Aqodad
Organ preservation strategy: new therapeutic alternative in rectal cancer. Journal of the Egyptian National Cancer Institute 35 (1) (2023)
F Safini, B Amaoui, S Semghouli, N Aqodad
Organ preservation strategy: new therapeutic alternative in rectal cancer. Journal of the Egyptian National Cancer Institute 35 (1) (2023)
Eman Mohamad Ibrahim, Sherine Refat, Shaimaa El-Ashwah, Maryan Waheeb Fahmi, Afaf Taha Ibrahiem
Programmed death ligand 1 expression in diffuse large B cell lymphoma: correlation with clinicopathological prognostic factors. Journal of the Egyptian National Cancer Institute 35 (1) (2023)
Sanaa A El-Benhawy, Ibrahim G Abdelrhman, Nadia A Sadek, Enayat I Fahmy, Ahmed A AboGabal, Hossam Elmasry, Sally A M Saleh, Ola A Sakr, Mona Nagy Elwany, Maha Abubakr Feissal Rabie
Studying ferroptosis and iron metabolism pre- and post-radiotherapy treatment in breast cancer patients. Journal of the Egyptian National Cancer Institute 35 (1) (2023)
Hesham Abdel-Azim El-Helaly, Asem Abdel-Aziz Mahmoud, Ahmed Mohamed Magdy, Abdelwahab Hashem, Hamdy Mohamed Ibrahim, Khaled Moheyelden Mohamed, Mohamed Hamdy Ismail
Impact of changing PI-RADS cutoff on prostate cancer detection by MRI cognitive fusion biopsy in biopsy-naïve patients. Journal of the Egyptian National Cancer Institute 35 (1) (2023)
Umesh Jayarajah, Ravindri Jayasinghe, Ashan Fernando, Sanjeewa Seneviratne
The incidence and trends of laryngeal malignancies in Sri Lanka from 2001 to 2019: a Joinpoint analysis of the national cancer database. Journal of the Egyptian National Cancer Institute 35 (1) (2023)
Nur Dina Amalina, Irfani Aura Salsabila, Ummi Maryam Zulfin, Riris Istighfari Jenie, Edy Meiyanto
In vitro synergistic effect of hesperidin and doxorubicin downregulates epithelial-mesenchymal transition in highly metastatic breast cancer cells. Journal of the Egyptian National Cancer Institute 35 (1) (2023)
Avinash Khadela, Bhavin Vyas, Mustakim Mansuri, Dipen Sureja, Kunjan Bodiwala
Impact of cetuximab plus cisplatin alone and cetuximab plus cisplatin and paclitaxel regimen on humanistic outcome in head and neck cancer. Journal of the Egyptian National Cancer Institute 35 (1) (2023)
Alaa Younes, Mohammad Fouad Taher, Iman Sidhom, Wael Zekri, Iman Zaky, Habiba Elfendy, Azza Niazy Taher, Suzan Adlan Khedr, Rana Gamal, Gehad Ahmed
Parotid gland masses: outcomes in the pediatric age group. Journal of the Egyptian National Cancer Institute 35 (1) (2023)
Rashed Pourhamidi, Azam Moslemi
Using the Precision Lasso for gene selection in diffuse large B cell lymphoma cancer. Journal of the Egyptian National Cancer Institute 35 (1) (2023)
Alaa Younes, Mohammad Fouad Taher, Iman Sidhom, Wael Zekri, Iman Zaky, Habiba Elfendy, Azza Niazy Taher, Suzan Adlan Khedr, Rana Gamal, Gehad Ahmed
Parotid gland masses: outcomes in the pediatric age group. Journal of the Egyptian National Cancer Institute 35 (1) (2023)
Alex Mwesigwa Mugisha, Zeridah Muyinda, Joyce Balagadde Kambugu, Denise Apolot, Elizabeth Atugonza, Anneth Teu, Aloysius Gonzaga Mubuuke
Observer agreement in single computerized tomography use for diagnosing paediatric head and neck malignancies at Uganda Cancer Institute. Journal of the Egyptian National Cancer Institute 35 (1) (2023)
Mona S El Ashry, Enas Radwan, Mona S Abdellateif, Omar Arafah, Naglaa M Hassan
Clinical features, laboratory characteristics, and outcome of ETP and TCRA/D aberrations in pediatric patients with T-acute lymphoblastic leukemia. Journal of the Egyptian National Cancer Institute 35 (1) (2023)
Mohammed Shahait, Ramiz Abu-Hijlih, Ala'a Farkouh, Shahed Obeidat, Samer Salah, Ahmed Saad Abdlkadir, Akram Al-Ibraheem
Fluorodeoxyglucose positron emission tomography (18F-FDG PET)-computed tomography (CT) in the initial staging of bladder cancer: a single institution experience. Journal of the Egyptian National Cancer Institute 35 (1) (2023)
Patrick Odhiambo, Harrison Okello, Annette Wakaanya, Clabe Wekesa, Patrick Okoth
Mutational signatures for breast cancer diagnosis using artificial intelligence. Journal of the Egyptian National Cancer Institute 35 (1) (2023)
Iyshwarya Bhaskar Kalarani, Ganesan Sivamani, Ramakrishnan Veerabathiran
Identification of crucial genes involved in thyroid cancer development. Journal of the Egyptian National Cancer Institute 35 (1) (2023)
Eman Mohamad Ibrahim, Sherine Refat, Shaimaa El-Ashwah, Maryan Waheeb Fahmi, Afaf Taha Ibrahiem
Programmed death ligand 1 expression in diffuse large B cell lymphoma: correlation with clinicopathological prognostic factors. Journal of the Egyptian National Cancer Institute 35 (1) (2023)
Seema Sandeep Redekar, Satishkumar L Varma, Atanu Bhattacharjee
Gene co-expression network construction and analysis for identification of genetic biomarkers associated with glioblastoma multiforme using topological findings. Journal of the Egyptian National Cancer Institute 35 (1) (2023)
Ibrahim Abdelrahman, Hatem Aboulkassem, Abdallah Elazab, Ahmed Younis Abdallah, Yahia Ismail, Mohammad Fouad Taher
Evaluation of short-term outcomes of neoadjuvant chemotherapy followed by radical cystectomy in muscle-invasive bladder cancer: a single Egyptian institution experience. Journal of the Egyptian National Cancer Institute 35 (1) (2023)
Ibrahim Abdelrahman, Hatem Aboulkassem, Abdallah Elazab, Ahmed Younis Abdallah, Yahia Ismail, Mohammad Fouad Taher
Evaluation of short-term outcomes of neoadjuvant chemotherapy followed by radical cystectomy in muscle-invasive bladder cancer: a single Egyptian institution experience. Journal of the Egyptian National Cancer Institute 35 (1) (2023)
Ahmed Daif, Mahmood A Al-Azzawi, Moustafa A Sakr, Hisham A Ismail, Mahmoud Gadallah
Noninvasive identification of molecular biomarkers of hepatocellular carcinoma in HCV-Egyptian patients. Journal of the Egyptian National Cancer Institute 35 (1) (2023)
Ibrahim Abdelrahman, Hatem Aboulkassem, Abdallah Elazab, Ahmed Younis Abdallah, Yahia Ismail, Mohammad Fouad Taher
Evaluation of short-term outcomes of neoadjuvant chemotherapy followed by radical cystectomy in muscle-invasive bladder cancer: a single Egyptian institution experience. Journal of the Egyptian National Cancer Institute 35 (1) (2023)
F Safini, B Amaoui, S Semghouli, N Aqodad
Organ preservation strategy: new therapeutic alternative in rectal cancer. Journal of the Egyptian National Cancer Institute 35 (1) (2023)
F Safini, B Amaoui, S Semghouli, N Aqodad
Organ preservation strategy: new therapeutic alternative in rectal cancer. Journal of the Egyptian National Cancer Institute 35 (1) (2023)
Mousa Fadaei, Maryam Kohansal, Omidreza Akbarpour, Mahsa Sami, Ali Ghanbariasad
Network and functional analyses of differentially expressed genes in gastric cancer provide new biomarkers associated with disease pathogenesis. Journal of the Egyptian National Cancer Institute 35 (1) (2023)
Emmanuel D Morgan, James J Yahaya, Advera I Ngaiza, Emmanuel Othieno, Okwi A Livex
Immunohistochemical expression of P53 protein in nephroblastoma: a predictor of unfavorable prognosis. Journal of the Egyptian National Cancer Institute 35 (1) (2023)
Sanaa A El-Benhawy, Ibrahim G Abdelrhman, Nadia A Sadek, Enayat I Fahmy, Ahmed A AboGabal, Hossam Elmasry, Sally A M Saleh, Ola A Sakr, Mona Nagy Elwany, Maha Abubakr Feissal Rabie
Studying ferroptosis and iron metabolism pre- and post-radiotherapy treatment in breast cancer patients. Journal of the Egyptian National Cancer Institute 35 (1) (2023)
Hesham Abdel-Azim El-Helaly, Asem Abdel-Aziz Mahmoud, Ahmed Mohamed Magdy, Abdelwahab Hashem, Hamdy Mohamed Ibrahim, Khaled Moheyelden Mohamed, Mohamed Hamdy Ismail
Impact of changing PI-RADS cutoff on prostate cancer detection by MRI cognitive fusion biopsy in biopsy-naïve patients. Journal of the Egyptian National Cancer Institute 35 (1) (2023)
Shinjini Bandopadhyay, Somi Patranabis
Mechanisms of HIF-driven immunosuppression in tumour microenvironment. Journal of the Egyptian National Cancer Institute 35 (1) (2023)
Mahmoud El-Bendary, Khaled Farid, Mohammad Arafa, Wagdi Elkashef, Talaat Abdullah, Ahmed El-Mesery
Prognostic value of S100A4 and Glypican-3 in hepatocellular carcinoma in cirrhotic HCV patients. Journal of the Egyptian National Cancer Institute 35 (1) (2023)
Nour Pharaon, Wafa Habbal, Fawza Monem
Bioinformatic analysis of KIT juxtamembrane domain mutations in Syrian GIST patients: jigsaw puzzle completed. Journal of the Egyptian National Cancer Institute 35 (1) (2023)
Sagiru Hamza Abdullahi, Adamu Uzairu, Gideon Adamu Shallangwa, Sani Uba, Abdullahi Bello Umar
Ligand-based drug design of quinazolin-4(3H)-ones as breast cancer inhibitors using QSAR modeling, molecular docking, and pharmacological profiling. Journal of the Egyptian National Cancer Institute 35 (1) (2023)
Nur Dina Amalina, Irfani Aura Salsabila, Ummi Maryam Zulfin, Riris Istighfari Jenie, Edy Meiyanto
In vitro synergistic effect of hesperidin and doxorubicin downregulates epithelial-mesenchymal transition in highly metastatic breast cancer cells. Journal of the Egyptian National Cancer Institute 35 (1) (2023)
Avinash Khadela, Bhavin Vyas, Mustakim Mansuri, Dipen Sureja, Kunjan Bodiwala
Impact of cetuximab plus cisplatin alone and cetuximab plus cisplatin and paclitaxel regimen on humanistic outcome in head and neck cancer. Journal of the Egyptian National Cancer Institute 35 (1) (2023)